# Kiadis Pharma N.V. — Form D

Kiadis Pharma N.V. of AMSTERDAM, P7, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-26. The offering totals $18.4M, of which $18.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-06-26
- Form: D
- Accession: 0001567619-19-014020
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $18.4M
- Amount sold: $18.4M
- Investors: 25
- Date of first sale: 2019-06-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-342850

## Issuer

- Name: Kiadis Pharma N.V.
- CIK: 0001780328
- Entity type: Limited Liability Company
- Jurisdiction: NETHERLANDS
- Incorporated: 2015
- Address: PAASHEUVELWEG 25A, AMSTERDAM, P7, 1105 BP
- Phone: 31 (0) 20 240 52 52

## Officers, directors & promoters (10)

| Name | Role | Location |
| --- | --- | --- |
| Martijn Kleijwegt | Director | Amsterdam, P7 |
| Berndt Modig | Director | Amsterdam, P7 |
| Subhanu Saxena | Director | Amsterdam, P7 |
| Otto Schwarz | Director | Amsterdam, P7 |
| Dr. Robert Soiffer | Director | Amsterdam, P7 |
| Mark Wegter | Director | Amsterdam, P7 |
| Scott A Holmes | Executive Officer | Amsterdam, P7 |
| James A Joy | Executive Officer | Amsterdam, P7 |
| Arthur Lahr | Executive Officer | Amsterdam, P7 |
| Mark A Schaefer | Executive Officer | Amsterdam, P7 |

## More

- [CIK 1780328 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1780328&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-19-014020.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.